Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Claudin-1, A Double-Edged Sword in Cancer.

Bhat AA, Syed N, Therachiyil L, Nisar S, Hashem S, Macha MA, Yadav SK, Krishnankutty R, Muralitharan S, Al-Naemi H, Bagga P, Reddy R, Dhawan P, Akobeng A, Uddin S, Frenneaux MP, El-Rifai W, Haris M.

Int J Mol Sci. 2020 Jan 15;21(2). pii: E569. doi: 10.3390/ijms21020569. Review.

2.

Exploring Dysregulated Signaling Pathways in Cancer.

Nisar S, Hashem S, Macha MA, Yadav SK, Muralitharan S, Azeez L, Sageena G, Al-Naemi H, Haris M, Bhat AA.

Curr Pharm Des. 2020 Jan 14. doi: 10.2174/1381612826666200115095937. [Epub ahead of print]

PMID:
31939726
3.

Tight Junction Proteins and Signaling Pathways in Cancer and Inflammation: A Functional Crosstalk.

Bhat AA, Uppada S, Achkar IW, Hashem S, Yadav SK, Shanmugakonar M, Al-Naemi HA, Haris M, Uddin S.

Front Physiol. 2019 Jan 23;9:1942. doi: 10.3389/fphys.2018.01942. eCollection 2018. Review.

4.

RAS-mediated oncogenic signaling pathways in human malignancies.

Khan AQ, Kuttikrishnan S, Siveen KS, Prabhu KS, Shanmugakonar M, Al-Naemi HA, Haris M, Dermime S, Uddin S.

Semin Cancer Biol. 2019 Feb;54:1-13. doi: 10.1016/j.semcancer.2018.03.001. Epub 2018 Mar 7. Review.

PMID:
29524560
5.

Knockout mice: is it just genetics? Effect of enriched housing on fibulin-4(+/-) mice.

Cudilo E, Al Naemi H, Marmorstein L, Baldwin AL.

PLoS One. 2007 Feb 21;2(2):e229.

Supplemental Content

Loading ...
Support Center